Free Trial

Teleflex (TFX) Stock Forecast & Price Target

$203.34
-0.06 (-0.03%)
(As of 11:51 AM ET)

Teleflex - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$257.29
26.53% Upside
High Forecast$285.00
Average Forecast$257.29
Low Forecast$219.00
TypeCurrent Forecast
6/25/23 to 6/24/24
1 Month Ago
5/26/23 to 5/25/24
3 Months Ago
3/27/23 to 3/26/24
1 Year Ago
6/25/22 to 6/25/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
7 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$257.29$261.75$265.56$273.38
Forecasted Upside26.53% Upside15.21% Upside13.61% Upside17.17% Upside
Get Teleflex Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

TFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Teleflex Stock vs. The Competition

TypeTeleflexMedical CompaniesS&P 500
Consensus Rating Score
2.63
2.70
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside26.49% Upside868.05% Upside10.90% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/3/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$240.00 ➝ $219.00+10.17%
5/3/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold
2/23/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Outperform ➝ Market Outperform$285.00+18.29%
2/23/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$272.00 ➝ $265.00+10.93%
12/20/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$227.00 ➝ $271.00+6.76%
12/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeEqual Weight ➝ Overweight$261.00+14.64%
11/6/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$210.00 ➝ $225.00+5.11%
11/3/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$275.00+31.60%
5/30/2023CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$293.00+24.97%
4/26/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Peer Perform
4/18/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Petrone
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Target$220.00 ➝ $250.00-4.09%
10/28/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$248.00 ➝ $229.00+6.23%
10/12/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$210.00+9.93%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:09 PM ET.

TFX Forecast - Frequently Asked Questions

What is Teleflex's stock forecast and purchase recommendation?

According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Teleflex is $257.29, with a high forecast of $285.00 and a low forecast of $219.00. The consensus rating for Teleflex stock is Moderate Buy based on the current 3 hold ratings and 5 buy ratings for TFX. Learn more on TFX's analyst rating history.

Do Wall Street analysts like Teleflex more than its competitors?

Analysts like Teleflex less than other "medical" companies. The consensus rating score for Teleflex is 2.63 while the average consensus rating score for "medical" companies is 2.70. Learn more on how TFX compares to other companies.

Does Teleflex's stock price have much upside?

According to analysts, Teleflex's stock has a predicted upside of 13.76% based on their 12-month stock forecasts.

What analysts cover Teleflex?

Teleflex has been rated by research analysts at Needham & Company LLC, and Truist Financial in the past 90 days.


Stock Forecasts and Research Tools

This page (NYSE:TFX) was last updated on 6/24/2024 by MarketBeat.com Staff

From Our Partners